Arvee Laboratories (India) Limited (ARVEE) fundamentals
Arvee Laboratories (India) Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as ARVEE (ISIN INE006Z01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Arvee Laboratories (India) Limited does
Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
Valuation and market data
| Last close | ₹180.69 |
|---|---|
| Market capitalisation | ₹199 crore |
| Enterprise value | ₹202 crore |
| P/E (TTM) | 0.00 |
| Price to book | 6.37 |
| Price to sales (TTM) | 4.75 |
| Book value per share | ₹28.35 |
| Dividend yield | 0.00% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Mon Mar 22 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹32 crore | ₹2 crore | ₹3 crore | 0.00 |
| Mar 2025 | ₹39 crore | ₹3 crore | ₹2 crore | 1.95 |
| Mar 2024 | ₹31 crore | ₹2 crore | ₹1 crore | 0.95 |
| Mar 2023 | ₹63 crore | ₹6 crore | ₹4 crore | 3.74 |
| Mar 2022 | ₹41 crore | ₹3 crore | ₹3 crore | 2.34 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 73.5% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 26.5% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.